John Neppl7:05
Thanks, Greg, and good morning, everyone. Let's turn to the earnings highlights from slide 8. We reported fourth-quarter earnings per share from continuing operations with a loss of 48 cents compared to a loss of 51 cents from the fourth quarter of 2018. Adjusted EPS was $1.27 in the fourth quarter versus 8 cents in the prior year. Our reported results included $239 million in net charges, of which approximately $102 million related to various portfolio initiatives and $76 million to the partial impairment of goodwill recorded on the acquisition of Loders Croklaan. We have achieved a vast majority of our targeted cost synergies associated with this acquisition. And although we are making progress on revenue synergies, we are achieving them at a slower pace than we had forecast when we completed the deal. Importantly, the goodwill write-down was a result of our annual impairment test and not triggered by a specific event. Loders is a unique asset and this charge does not change our positive view on this business or its long-term potential. Total segment earnings before interest and taxes, or EBIT, was $44 million in the quarter versus $70 million in the prior year. On an adjusted basis, total segment EBIT was $283 million in the quarter versus $107 million in the prior year. Agribusiness adjusted EBIT of $177 million compared to $55 million last year. Higher segment results in the quarter reflected improved execution, particularly in managing risk throughout our grain and oilseed value chains, and well speeds. Lower soy processing in the U.S. and Europe reflected particularly strong margins a year ago. Soft seed results improved when compared to last year due to strong oil demand and seed supplies. As expected, oilseeds results were negatively impacted by approximately $95 million of mark-to-market reversals on soy crushing contracts which favorably impacted our third quarter results. An increase in soybean crush margins during the fourth quarter resulted in new mark-to-market losses on forward contracts. However, these losses were largely offset by mark-to-market gains on forward hedges related to our soft seed and palm oil supply chains that serve our downstream edible oil to customers. As a result, we enter 2020 with only a small net mark-to-market balance.
Improved results in oilseed trading and distribution were primarily due to better positioning in grain. Higher results were primarily driven by origination in South America. Brazilian farmers selling increased as local prices improved, and in Argentina, farmers accelerated sales in anticipation of a change in export taxes. Ocean freight results benefited from good fleet positioning and management. Food and Ingredients adjusted EBIT of $84 million compared to $73 million in Q4 2018. Edible oils adjusted results of $67 million were up $11 million from last year, driven by better results in North America and Asia, which more than offset lower results from South America. Results in Europe were comparable to last year, excluding approximately $13 million in favorable timing differences on hedges that will reverse in 2020; segment results were lower than in prior year. Milling adjusted EBIT of $17 million for the quarter was similar to the prior year as higher results in Mexico were offset by lower results in the U.S. and Brazil. Sugar and bioenergy fourth quarter 2019 results reflect Bunge's ownership through November. Adjusted EBIT of $52 million in the quarter was $100 million higher than in the prior year. The increase is mainly due to improved agricultural yields and operational execution that drove a lower unit cost, as well as higher Brazilian ethanol pricing and higher sugar pricing and volume. Results also benefit from approximately $38 million of lower depreciation when compared to last year, due primarily to the business being classified held for sale. Fertilizer adjusted EBIT of $26 million was in line with the prior year.
Adjusting for all notable items, affected tax rate for the year was approximately 16%. The lower-than-expected tax rate was primarily due to earnings mix as we reported strong fourth-quarter results in regions of favorable tax rate. Let's turn to slide 9. SG&A: when the company announced its global competitiveness program in July 2017, the goal was to achieve a reduction in SG&A cost of $250 million by the end of 2020 as compared to a 2017 addressable SG&A baseline of $1.35 billion. With hard work and the commitment of our employees, Bunge achieved the savings target one year ahead of plan. This slide bridges the savings to what we report in our SG&A expense line, reflecting unaddressable cost changes in our business portfolio such as the Loders Croklaan acquisition and other factors that impact our SG&A such as inflation, foreign exchange, GCP program costs, and variable compensation. The $252 million in cost reductions is roughly equally split between indirect spending and employee costs. The company incurred approximately $150 million of one-time execution costs over the life of this program. Moving to slide 10, cash flow highlights. For 2019, we generated approximately $1.1 billion of adjusted funds from operations, similar level to prior year. The cash flow generation enabled us to comfortably fund our capex and dividend and reduce our debt. As you can see on slide 11, our debt largely finances our inventories, with approximately 80% of our net debt being used to finance readily marketable inventory. At the end of 2019, working capital ended the year a bit higher than we were targeting, primarily due to elevated commercial activity in Q4, especially in South America, resulting in increases in farmer advances, accounts receivable balances, and unrealized gains on derivatives used to hedge commercial commitments.
Turning to slide 12, we have committed credit facilities of approximately $4.3 billion, all of which was available at the end of the quarter, and we had a cash balance of $320 million. Total committed credit facilities dropped from $5 billion last quarter to $4.3 billion as a result of a $700 million revolving credit facility being converted into a term loan and then transferred on a non-recourse basis to the sugar and bioenergy joint venture. Proceeds received from the $700 million debt transfer and a further $75 million received from BP were largely used to pay down balances outstanding under the company's commercial paper program and credit facilities. Moving to slide 13, in our full-year summary of capital allocation, we generated adjusted funds from operations of approximately $1.1 billion. From this, total capex spending was $524 million, which was about $25 million below our original guidance for the year. This included $118 million in capex for sugar and bioenergy which will not be incurred by Bunge going forward. We paid $317 million in dividends to shareholders. This left us with approximately $215 million of retained cash flow that we allocated toward debt reduction and working capital.
Please turn to slide 14. In return on invested capital, our trailing four-quarter average adjusted return on invested capital was 7.9% overall, well above the 5% the prior year. Excluding our sugar and bioenergy segment, our ROIC was 7.7% versus 6.5% last year. We are currently reviewing our stated weighted average cost of capital of 7%. Based on our preliminary review, we believe that 7% we have been referring to you may be higher than actual WACC. If we determine there is a more appropriate rate to use going forward, we will communicate that in a future quarter. Whether or not we make that change, our target and our ROIC of 9% will remain unchanged. Moving to slide 15, in our outlook for 2020. As Greg mentioned in his remarks, we expect 2020 EPS to be largely in line with what we earned in 2019 when excluding notable items, our gain on Beyond Meat, and the depreciation benefit in the sugar and bioenergy segment. In agribusiness, we expect full-year results to be down from 2019 based upon current forward market structure. However, actual origination, processing, and distribution margins will evolve based on the fulfillment of the U.S.-China trade agreements, crop sciences, and further commercialization. In Food and Ingredients, we expect full-year results in edible oils and milling to be similar to 2019, excluding approximately $13 million in favorable Q4 2019 timing differences, which are expected to be negative to 2020. In fertilizer, we expect full-year results to be down versus a particularly strong 2019, and for results to be similar to 2018. In sugar and bioenergy, market fundamentals have improved versus 2019 driven by sustained Brazilian ethanol market prospects and better year-over-year leader prices. For 2020, we expect an effective tax rate in the range of 19 to 23 percent, interest expense of approximately $230 million, capex from the range of $400 to $450 million, and depreciation and amortization of approximately $465 million. With that, I'll turn the call back over to Greg for some closing comments.